Literature DB >> 10992536

Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects.

M J Plummeridge1, L Armstrong, M A Birchall, A B Millar.   

Abstract

BACKGROUND: Asthma is characterised pathologically by an inflammatory pulmonary infiltrate rich in T helper (Th) 2 cells and eosinophils. Interleukin (IL)-12 is a heterodimeric cytokine critical for driving the development of uncommitted Th cells to express a Th 1 phenotype. Reduced pulmonary production of IL-12 may therefore play a role in the pathogenesis of asthma by contributing to the pulmonary cytokine imbalance seen in asthma.
METHODS: IL-12 p70 protein levels in bronchoalveolar lavage fluid and p70 protein levels and IL-12 messenger RNA in alveolar macrophage cultures from normal and atopic asthmatic subjects were measured.
RESULTS: There was a significant difference between the mean IL-12 p70 protein level in the bronchoalveolar lavage fluid from asthmatic subjects (37.5 pg/ml) and from normal subjects (131 pg/ml, p = 0.04). Alveolar macrophages from asthmatic subjects produced significantly less IL-12 protein (30 pg/ml) and messenger RNA than those from normal subjects (69.5 pg/ml, p<0.005). These differences were not caused by inhibition of IL-12 production by IL-10 nor to generalised hyporesponsiveness of asthmatic alveolar macrophages from subjects to the effects of interferon (IFN)-gamma.
CONCLUSIONS: Pulmonary IL-12 production is lower in asthmatic subjects. This reduction is not the result of generalised hyporesponsiveness to IFN-gamma. Reduced IL-12 levels may contribute to the development of asthmatic pulmonary inflammation through dysregulation of Th cell development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992536      PMCID: PMC1745617          DOI: 10.1136/thorax.55.10.842

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

1.  Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy.

Authors:  T Naseer; E M Minshall; D Y Leung; S Laberge; P Ernst; R J Martin; Q Hamid
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

2.  Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance.

Authors:  T R Martin
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

3.  IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity.

Authors:  M Humbert; S R Durham; S Ying; P Kimmitt; J Barkans; B Assoufi; R Pfister; G Menz; D S Robinson; A B Kay; C J Corrigan
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

4.  Alveolar tissue inflammation in asthma.

Authors:  M Kraft; R Djukanovic; S Wilson; S T Holgate; R J Martin
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

5.  Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection.

Authors:  T S Harrison; S M Levitz
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

6.  Interleukin-10 regulation in normal subjects and patients with asthma.

Authors:  L Borish; A Aarons; J Rumbyrt; P Cvietusa; J Negri; S Wenzel
Journal:  J Allergy Clin Immunol       Date:  1996-06       Impact factor: 10.793

7.  Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.

Authors:  B Galve-de Rochemonteix; L P Nicod; J M Dayer
Journal:  Am J Respir Cell Mol Biol       Date:  1996-03       Impact factor: 6.914

8.  IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones.

Authors:  S Maruo; K Toyo-oka; M Oh-hora; X G Tai; H Iwata; H Takenaka; S Yamada; S Ono; T Hamaoka; M Kobayashi; M Wysocka; G Trinchieri; H Fujiwara
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

9.  Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma.

Authors:  M A Spiteri; R A Knight; J Y Jeremy; P J Barnes; K F Chung
Journal:  Eur Respir J       Date:  1994-08       Impact factor: 16.671

10.  Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.

Authors:  S H Gavett; D J O'Hearn; X Li; S K Huang; F D Finkelman; M Wills-Karp
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  7 in total

Review 1.  What does tympanostomy tube placement in children teach us about the association between atopic conditions and otitis media?

Authors:  Young J Juhn; Chung-Il Wi
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

2.  Interleukin-12 peripheral blood levels in asthmatic children.

Authors:  Ruth Soferman; Idit Rosenzwig; Elizabeth Fireman
Journal:  Allergy Asthma Clin Immunol       Date:  2007-12-15       Impact factor: 3.406

Review 3.  Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?

Authors:  Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2014-08       Impact factor: 10.793

4.  Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness.

Authors:  Teal S Hallstrand; Emil Y Chi; Alan G Singer; Michael H Gelb; William R Henderson
Journal:  Am J Respir Crit Care Med       Date:  2007-09-27       Impact factor: 21.405

Review 5.  Viruses exacerbating chronic pulmonary disease: the role of immune modulation.

Authors:  Aran Singanayagam; Priya V Joshi; Patrick Mallia; Sebastian L Johnston
Journal:  BMC Med       Date:  2012-03-15       Impact factor: 8.775

6.  Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients.

Authors:  Thomas Southworth; Jonathan Plumb; Vandana Gupta; James Pearson; Isabel Ramis; Martin D Lehner; Montserrat Miralpeix; Dave Singh
Journal:  Respir Res       Date:  2016-10-04

7.  Asthma and risk of non-respiratory tract infection: a population-based case-control study.

Authors:  Duk Won Bang; Hyeon J Yang; Eell Ryoo; Majdi N Al-Hasan; Brian Lahr; Larry M Baddour; Barbara P Yawn; Young J Juhn
Journal:  BMJ Open       Date:  2013-10-03       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.